Product Information

METHYLPHENIDATE ER(LA) 40 MG CP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.1861 per EA under NDC 00093534801. Its NADAC has been published 657 times since Nov 28, 2013.

METHYLPHENIDATE ER(LA) 40 MG CP

Methylphenidate Hydrochloride
$2.1861per EA
DEA Schedule CII

Strength

40 mg/1

NDC

00093534801

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA079031

On Market Since

7/16/2012

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER(LA) 40 MG CP has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 45.1%. The table below summarizes its recorded NADAC range and movement.

Current price$2.1861 per EA
All-time high$4.9797 (Aug 12, 2015)
All-time low$1.0281 (Dec 22, 2021)
52-week high$2.8322
52-week low$2.0505
Median price$3.0784
Average price$3.2134
Largest weekly change+92.7% (Apr 19, 2023)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-5.5%

3M

-7.3%

6M

-22.8%

1Y

+6.6%

3Y

-4.7%

5Y

+52.5%

All

-45.1%

Generic Alternatives

The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER(LA) 40 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(LA) 40 MG CP, manufactured by Teva Pharmaceuticals USA Inc., is $2.1861 per EA (NDC 00093534801), effective Jun 24, 2026.

How has the price of METHYLPHENIDATE ER(LA) 40 MG CP changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER(LA) 40 MG CP has declined 45.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(LA) 40 MG CP?

Since Nov 28, 2013, the NADAC for METHYLPHENIDATE ER(LA) 40 MG CP has ranged from a low of $1.0281 (Dec 22, 2021) to a high of $4.9797 (Aug 12, 2015), with a median of $3.0784 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER(LA) 40 MG CP?

Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METHYLPHENIDATE ER(CD) 40 MG CP, is $1.4221 per EA — about 35% below METHYLPHENIDATE ER(LA) 40 MG CP.

Who manufactures METHYLPHENIDATE ER(LA) 40 MG CP?

METHYLPHENIDATE ER(LA) 40 MG CP (NDC 00093534801) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.